SCHEMBL819552

SCHEMBL819552

C=CC(=O)Oc1c(OC)ccc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.49
MTNR1A P48039 2/20 0.47
MTNR1B P49286 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HPGD P15428 2/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP1A1 P04798 1/20 0.44
CYP1B1 Q16678 1/20 0.44
NCEH1 Q6PIU2 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42
BACE1 P56817 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28017827 0.89 TYMS (0.46) MAPTHPGDCYP1A1CYP1B1NCEH1
SCHEMBL29277282 0.88 CYP1A1 (0.47) MAPTMTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL19125087 0.84 TYMS (0.39) MAPTCYP1A2CYP2C9CYP2C19HPGD
SCHEMBL455028 0.83 MAPT (0.53) MAPTMTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL29357471 0.83 MAPT (0.53) MAPTMTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL30226686 0.82 HTR1A (0.43) CYP3A4KDM4EL3MBTL1ALDH1A1HTT
SCHEMBL27947715 0.81 TSHR (0.43) MAPTCYP1A2HPGDKDM4ECYP1A1
SCHEMBL11865826 0.81 MAPT (0.51) MAPTMTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL30226804 0.81 TYMS (0.50) MAPTCYP1A2CYP3A4CYP2C9HPGD
SCHEMBL68670 0.81 TYMS (0.50) MAPTCYP1A2CYP3A4CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740235-B1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SURMODICS INC (US) 2009-07-22 EP claimed
US-7544673-B2 Coating compositions for bioactive agents SURMODICS, INC. (US) 2009-06-09 US claimed
US-7541048-B2 Coating compositions for bioactive agents SURMODICS, INC. (US) 2009-06-02 US claimed
JP-2007532187-A 2007-11-15 JP claimed
JP-2007532197-A 2007-11-15 JP claimed
EP-1740236-A2 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SurModics, Inc. (US) 2007-01-10 EP claimed
EP-1740235-A1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SurModics, Inc. (US) 2007-01-10 EP claimed
US-20050244459-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-11-03 US claimed
WO-2005099787-A1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SURMODICS, INC. (US) 2005-10-27 WO claimed
WO-2005099786-A1 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SURMODICS, INC. (US) 2005-10-27 WO claimed
WO-2005097228-A2 COATING COMPOSITIONS FOR BIOACTIVE AGENTS SURMODICS, INC. (US) 2005-10-20 WO claimed
US-20050220840-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220841-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220843-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220839-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
US-20050220842-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US claimed
CN-117222651-A Novel compound and organic light emitting device comprising the same 株式会社LG化学 2023-12-12 CN disclosed
EP-2265293-B1 COATING SYSTEMS FOR THE CONTROLLED DELIVERY OF HYDROPHILIC BIOACTIVE AGENTS SURMODICS INC (US) 2015-11-04 EP disclosed
US-20050220840-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US disclosed
US-20050220841-A1 Coating compositions for bioactive agents Surmodics Coatings, LLC 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050220839-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 MAPT 3986/4885MTNR1A 3140/4885MTNR1B 3215/4885
US-20050220841-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 MAPT 3986/4885MTNR1A 3140/4885MTNR1B 3215/4885
US-20050220843-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 MAPT 3986/4885MTNR1A 3140/4885MTNR1B 3215/4885
US-20050220842-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 MAPT 3986/4885MTNR1A 3140/4885MTNR1B 3215/4885
US-20050220840-A1 Coating compositions for bioactive agents BMP2, FGF23, TGFB1 MAPT 3986/4885MTNR1A 3140/4885MTNR1B 3215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.